Judges said HHS exceeded its legal authority by requiring drug price disclosure as part of its stewardship of Medicare, Medicaid
THURSDAY, June 18, 2020 (HealthDay News) — The U.S. government does not have the legal authority to force drug companies to disclose prices in their TV ads, a federal appeals court says.
The unanimous decision Tuesday by a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit did not address the drug industry’s contention that forcing companies to disclose their prices in ads violates their free speech rights, the Associated Press reported.
The panel said the Department of Health and Human Services exceeded its legal authority by requiring drug price disclosure as part of its stewardship of Medicare and Medicaid.
HHS “acted unreasonably” in claiming it had authority to impose “a sweeping disclosure requirement that is largely untethered to the actual administration of the Medicare or Medicaid programs,” Judge Patricia Millett wrote for the court, the AP reported.
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines 
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death 
Hypoglossal Nerve Stimulation May Offer Long-Term Cardiovascular Benefits in OSA 
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA 
2018 to 2024 Saw Rise in Insurance Denials for Brand-Name Drugs 
